Reasons to Choose the Biomarker Operations & Biospecimen Management Summit
Biomarker operations has quietly become one of the most consequential functions in clinical development, and one of the least served. With trials increasingly becoming more global, more sample-intensive and more operationally complex, the people responsible for delivering a specimen from a patient's arm to an analysis-ready dataset, are carrying more risk than ever, with no dedicated forum in which to solve it.
Whilst other meetings take a slice, data conferences cover the analytics, and lab conferences cover the assays. None cover the whole chain, which is exactly where the failures happen: at the hand-offs between kit design and site execution, between consent and downstream use, and between the central lab and the sponsor's data team.
This forum is built solely around the lifecycle, to reflect exactly how the job is completed.
What You Can Expect
Our Relevance
Every session is built from the operational realities this community is dealing with right now, from pre-analytical variability across global sites through to post-trial disposition strategies, that balance cost against future scientific value.
The agenda was crafted through direct conversations with biomarker operations, biospecimen management and clinical operations leaders across pharma and biotech.
What We Will Deliver
Over two days, you will cover the biospecimen journey end-to-end, across presentations, interactive roundtable and panel sessions, and dedicated networking.
Joining us will equip you with the practical approaches to implement standardized collection and handling across global sites, operationalized consent and withdrawal tracking, and the knowledge to apply AI to reduce the manual reconciliation burden that consumes so much of this function's capacity.
Our Impact
This is the first time the biomarker operations and biospecimen management community has convened under one roof. This matters as the largest hurdles facing the field cannot be solved by any one stakeholder: they sit across sponsors, sites, central labs, technology providers and biobanks.
We are offering a communal space to set shared standards and build stronger operational infrastructures, so that every specimen delivers the data it was collected for, and every patient's time, trust and discomfort is honoured with the rigour it deserves.
Who You Will Connect With
Pharma Giants
Biotech Pioneers
Discover the New Agenda
Hear the latest breakthroughs in biomarker operations and gain exclusive insights across industry-led sessions, interactive BMC roundtables, and discussion-based panels
Partner With the Future
Position your organization directly alongside the architects of modern biomarker operations to ensure your brand is at the heart of every sample lifecycle decision
Join Biomarker Stakeholders
Be part of the first forum dedicated to this space, connecting with senior decision-makers from biopharma, central labs, and diagnostics across two action-packed conference days